Nuclear Medicine & PET-CT Specialist

Dr. Priyanka Korepu

Consultant & Head – Nuclear Medicine, PET CT & Theranostics

MBBS, DNB, FEBNM, RSO

Regd. No: APMC/FMR/76000

Biography

Dr. Priyanka Korepu is a highly specialized Nuclear Medicine Physician and the current Department Head at Prathima Cancer Institute. With over a decade of clinical experience, she is an expert in molecular imaging and targeted radionuclide therapies, effectively bridging the gap between metabolic diagnosis and clinical treatment. Her expertise spans the critical fields of Oncology, Cardiology, and Neurology, focusing on identifying diseases at a cellular level through hybrid imaging like PET-CT and SPECT-CT before structural changes become visible on conventional scans.

As a certified Radiological Safety Officer (RSO), Dr. Priyanka Korepu has a proven track record of establishing Nuclear Medicine departments from the ground up, ensuring rigorous adherence to AERB and eLORA safety standards. Her leadership extends to managing teams of technical and non-technical staff, driving operational excellence in complex diagnostic environments.

DNB in Nuclear Medicine: Completed at Jaslok Hospital, Mumbai (2016–2019).
MBBS: Earned from Mediciti Institute of Medical Sciences (MIMS), Hyderabad.
European Fellowship in Nuclear Medicine (FEBNM): Awarded in 2021.
Radiological Safety Officer (RSO): Certified for radiation safety management.
Specialized Workshops: Includes training in Nuclear Medicine Therapy at AIIMS, New Delhi, and Radiation Safety at Tata Memorial Hospital.
Early Medical Training: Served as a Junior Resident in Neurointensive care at NIMHANS and Cardiac Surgical ICU at Fortis Health Care.

Consultant & Head – Nuclear Medicine, PET CT & Theranostics: Prathima Cancer Institute, Warangal (April 2024 – Present).
Chief Consultant and Head PET CT: Superia PET CT Diagnostic Centre, Hyderabad (May 2023 – March 2024).
Consultant & Head – Nuclear Medicine, PET CT & RSO: Omega Bannu Cancer Hospital (December 2021 – April 2023).
Nuclear Medicine Consultant: Newmedd Diagnostics, Bangalore (July 2019 – October 2021).
DNB Resident: Jaslok Hospital, Mumbai (March 2016 – March 2019).
Non-PG Junior Resident in the department of Cardiothoracic ICU at Fortis Hospital, Bannerghatta Road (2013 – 2014)
Non-PG Junior Resident in the department of Neuroanaesthesia and Neurointensive care, NIMHANS, Bangalore (2012 – 2013)

International Recognition: Awarded the European Fellowship in Nuclear Medicine (FEBNM) in 2021.
Research Excellence: Won “Best Poster Presentation” at MDSICON (2021–2022) for her comparative study on Parkinsonism diagnosis.
Operational Success: Established SPECT and High-Dose Therapy wards, successfully managing all AERB licensing and safety protocols.
Global Engagement: Served as a delegate at the 37th Annual Congress of the EANM in Hamburg, Germany (2024).

Book Chapter: Co-authored the “Nuclear Medicine in Movement Disorders” chapter in the 2nd Edition of Parkinson’s Disease and Movement Disorders.
Journal Articles:
Author of “Hyperpyrexia following Hemispherotomy and the role of unconventional therapy” in the Journal of Neuroanaesthesiology and Critical Care.
“Blinded Comparative Analysis of 99mTc-Trodat SPECT-CT, FDG PET-CT and MRI Scans in the Diagnosis of Parkinsonism” was published in the supplement of Annals of Movement Disorders.
Case study on the utility of 68Ga-PSMA PET-CT in Prostate carcinoma compared with mpMRI.

Theranostics Expert: Specializes in Lutetium-177-based therapies (PSMA, DOTATATE) for advanced cancers and Radioiodine therapy for thyroid conditions.
Advanced Oncology Imaging: Expertise in FDG PET-CT and advanced tracers such as PSMA, DOTATATE, FAPI, and EXENDIN.
Neurology & Cardiology: Utilizes Brain PET and TRODAT SPECT for diagnosing Parkinson’s and epilepsy; performs myocardial perfusion imaging for heart disease.
Radiation Safety: Expert in eLORA portal management for licensing and radiation protection surveys.
Educational Leadership: Mentors juniors, interns, and technologists; produced over 20 high-quality educational videos on YouTube.

Parkinsonism: Conducted extensive comparative analysis between SPECT-CT, PET-CT, and MRI to refine diagnostic protocols for movement disorders.
Prostate Cancer: Investigated the comparative efficacy of Ga-68 PSMA PET-CT against multiparametric MRI (mpMRI).
Radiopharmaceutical Quality: Researched the retention of radioactivity in delivery systems (Tc-99m Tetrofosmin) to ensure dosing accuracy in myocardial perfusion imaging.

SNMICON – Ahmedabad (2016)
ANMPICON – Cochin (2018)
MDSICON – Mumbai (2021-22)
EANM (Virtual) – Hamburg, Germany (2024)
SNMICON – Coimbatore (2024)
ANMPICON – Hyderabad (2025)

Cliniconuclear Correlation CME at Pune in July 2016
NBE workshop on research methodology at Indian Institute of Public Health, Hyderabad, in October 2016
Radiation Safety Workshop, Tata Memorial Hospital, Mumbai in November 2017
Preceptorship (Hands-on Training in Nuclear Medicine Therapy) in the Department of Nuclear Medicine, AIIMS, New Delhi in March 2018
Update on Prostate Cancer CME at Jaslok Hospital, Mumbai in July 2018
Physics Practical Workshop at Radiation Medicine Centre, Mumbai in February 2019

SNMI – Society of Nuclear Medicine, India
ANMPI – Association of Nuclear Medicine Physicians of India

Oncology Imaging: Expertise in FDG PET-CT and advanced tracers like PSMA, DOTATATE, FAPI, and EXENDIN for precise cancer staging, therapy response, surveillance & restaging.
Radionuclide Therapy (Theranostics): Specialized in Lutetium-177-based therapies (PSMA, DOTATATE) for advanced cancers and Radioiodine therapy for thyroid conditions.
Neurological Applications: Utilizing Brain PET and TRODAT SPECT for the diagnosis of Parkinson’s disease, dementia, and refractory epilepsy.
Cardiac Nuclear Medicine: Performing myocardial perfusion imaging and viability assessments for ischemic heart disease.
General Nuclear Medicine: Comprehensive reporting for renal, bone, thyroid, parathyroid, lymphoscintigraphy, and hepatobiliary (HIDA) scans.